[{"id":"e9b8f656-3e3e-4dac-9919-54a580d0b8b5","acronym":"","url":"https://clinicaltrials.gov/study/NCT04137406","created_at":"2021-01-18T20:12:23.316Z","updated_at":"2024-07-02T16:36:54.271Z","phase":"","brief_title":"Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis","source_id_and_acronym":"NCT04137406","lead_sponsor":"Peking University People's Hospital","biomarkers":" BCL2 • SIRT1","pipe":"","alterations":" ","tags":["BCL2 • SIRT1"],"overall_status":"Unknown status","enrollment":" Enrollment 160","initiation":"Initiation: 01/01/2019","start_date":" 01/01/2019","primary_txt":" Primary completion: 12/30/2020","primary_completion_date":" 12/30/2020","study_txt":" Completion: 12/30/2020","study_completion_date":" 12/30/2020","last_update_posted":"2019-10-24"},{"id":"c793b73e-238c-4a86-b184-43cb1d84cb73","acronym":"","url":"https://clinicaltrials.gov/study/NCT03615391","created_at":"2021-01-18T17:46:01.138Z","updated_at":"2024-07-02T16:37:08.318Z","phase":"","brief_title":"Predictive Role and HuR Mechanisms of Regulation in the Brain Tumours","source_id_and_acronym":"NCT03615391","lead_sponsor":"Central Hospital, Nancy, France","biomarkers":" BCL2 • CCND1 • VEGFA • HIF1A • CASP3 • ATF6 • ERN1 • MIR16 • SIRT1 • MCM6","pipe":"","alterations":" ","tags":["BCL2 • CCND1 • VEGFA • HIF1A • CASP3 • ATF6 • ERN1 • MIR16 • SIRT1 • MCM6"],"overall_status":"Unknown status","enrollment":" Enrollment 140","initiation":"Initiation: 10/01/2012","start_date":" 10/01/2012","primary_txt":" Primary completion: 10/01/2015","primary_completion_date":" 10/01/2015","study_txt":" Completion: 10/01/2020","study_completion_date":" 10/01/2020","last_update_posted":"2018-08-03"},{"id":"11a75896-ed72-4de4-bf64-92a7e752fb1f","acronym":"","url":"https://clinicaltrials.gov/study/NCT03158324","created_at":"2021-01-18T15:34:16.926Z","updated_at":"2024-07-02T16:37:21.037Z","phase":"Phase 2a","brief_title":"Phase IIa Dose-Expansion and Biomarker Study of OPB-111077","source_id_and_acronym":"NCT03158324","lead_sponsor":"National University Hospital, Singapore","biomarkers":" EGFR • BRAF • ALK • EML4 • SIRT1","pipe":" | ","alterations":" EGFR mutation • BRAF mutation • ALK positive • EML4-ALK fusion • ALK fusion • ALK mutation • RET mutation","tags":["EGFR • BRAF • ALK • EML4 • SIRT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • BRAF mutation • ALK positive • EML4-ALK fusion • ALK fusion • ALK mutation • RET mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e OPB-111077"],"overall_status":"Unknown status","enrollment":" Enrollment 52","initiation":"Initiation: 05/22/2017","start_date":" 05/22/2017","primary_txt":" Primary completion: 05/22/2020","primary_completion_date":" 05/22/2020","study_txt":" Completion: 11/30/2020","study_completion_date":" 11/30/2020","last_update_posted":"2017-06-15"}]